{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910583361603321"]
[null,null,"Autore",null,"Friel Howard"]
[null,null,"Titolo",null,"A paradigm shift to prevent and treat Alzheimer's disease : from monotargeting pharmaceuticals to pleiotropic plant polyphenols / / Howard Friel and Sally Frautschy"]
[null,null,"Pubbl/distr/stampa",null,"London, England : , : Academic Press, , 2017"]
[{"$nulls":4},"©2017"]
[null,null,"ISBN",null,"0-12-812279-X"]
[{"$nulls":4},"0-12-812259-5"]
[null,null,"Descrizione fisica",null,"1 online resource (275 pages) : illustrations"]
[null,null,"Disciplina",null,"616.831061"]
[null,null,"Soggetti",null,"Alzheimer's disease - Chemotherapy"]
[{"$nulls":4},"Alzheimer's disease - Prevention"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Part I. Pleiotropism -- Monotargeting versus multitargeting -- The pleiotropic pharmacology of plant polyphenols -- Part II. Pleiotropism and Alzheimer's disease -- Primary prevention of Alzheimer's disease -- Secondary prevention of Alzheimer's disease -- Treatment mechanisms in mild to moderate Alzheimer's disease --Pleiotropic theory -- Part III. Rational basis versus strict scrutiny -- Dose-adherence and intent-to-treat."]